It was over forty years ago, as a young trainee in Internal Medicine at Chicago that I took care of a young man with a brain infection caused by a “rare” parasite named Toxoplasma gondii. We were indeed perplexed to see an otherwise ostensibly healthy and vigorous young man afflicted by a condition only reported in individuals with severe defects of the immune system. We had become aware of strange infections in young men who on further evaluation turned out to have severe defects of their immune system. The only other information was an epidemiological pattern of afflicted individuals suggesting the possibility of a contagious illness linking this strange disorder now termed Acquired Immunodeficiency Syndrome (AIDS).
On further evaluation, our young patient had the same kind of defects of the immune system reported in this strange new illness called AIDS. As events unfolded, I witnessed firsthand the horror of paranoia that prevailed in the health professionals I worked with. The fact is we knew even then, based on epidemiologic evidence, that this illness could be acquired only through sexual contact or transfusions of blood products and needle sharing practices of intravenous substance abuse. That irrational paranoia could erase any compassion in health care professionals was inexplicable and deeply distressing. I could see how it impaired access to proper evaluation and care of this young man as he unfortunately suffered kidney failure due to the high doses of antibiotics used for the treatment of his brain abscess. Specialists, whose consultation was requested, politely declined to pitch in quoting their nihilistic opinion of the dismal prognosis and futility of intervention.
Over the years we learned more about the epidemiology and natural history along with the discovery of the causative agent, a retrovirus eventually named: Human Immunodeficiency Virus (HIV). Diagnostic methods improved and the virus could be detected before symptomatic illness became manifest. I had at this time made up my mind to develop the skills to care for these unfortunate individuals shunned by the fraternity to which I belonged. I was accepted into the Infectious Diseases Fellowship Program at Loyola University Medical Center in Chicago where my mentors helped me learn scientific skills, and my patients taught me the incomparable efficacy of love, compassion and hope. It is my patients who taught me to reject fatalism and to persevere in exploring every new advance in science and technology to improve the care of my patients with HIV. It is my patients who taught me the power of organizing to combat stigma and discrimination that prevented people from testing for HIV. The discovery of infection would often lead to loss of employment and estrangement from friends and family. It would bring home to me and many kindred souls the need to complement our scientific temperament with values of social justice appreciating cultural competence as a core attribute of a health care professional.
Over the years as the devastation of the HIV pandemic unfolded we watched with unmitigated horror the disproportionate impact on the poorest all over the world and the callous disregard of the elite who would label HIV as the self-inflicted punishment for those, they considered the “Others”. What is a strictly infectious disease of grave public health significance requiring urgent public health response and resources fell victim to distorted and discriminatory neglect, rooted in ignorance and bigotry of the worst kind further marginalizing people infected and affected by HIV.
Early in my career I took care of “CS” a healthcare colleague who suffered almost every opportunistic infection afflicting people with HIV. He taught me never to be complacent about newer developments as he chided me about my conservative outlook waiting for evidence from “Controlled Clinical Trials” as the official gospel for managing HIV. Indeed, it is pressure from organized groups of infected/affected people who impressed upon us the need for urgency in developing faster and more efficient ways of evaluating newer regimens for managing HIV. Most of the innovative and truly impressive advances in addressing the HIV pandemic have come from effective community engagement and ensuring their active participation in the design and implementation medical research and public health. Most gratifyingly these paradigms are now being extended to other realms of health sciences research.
I first started my work in India addressing the HIV pandemic in the year 2000. I must say that the only reason I could start in India were several intrepid health professionals who were kind enough to contribute to and guide me- on my altogether rather short visits- giving talks on HIV and complications.
Recognizing the need for a coherent and consistent program they worked diligently on building the capacity to test and treat people with HIV and also work on building awareness in the community at large about facts regarding HIV and dispelling myths. This work first led to routinely testing all blood products for HIV infection and then analyzing the data. What we uncovered was the disconcerting fact that pregnant women in rural parts of Hyderabad had three times as much HIV infection as volunteer blood donors in urban Hyderabad. Clearly, HIV being a problem restricted to high-risk groups was a myth blown away by this revelation. This was the impetus for us to expand our awareness campaigns and to promote voluntary counselling and testing in peri-urban Hyderabad. We found that not only were around 1% of the sexually active people infected, but that the women discovered to have HIV infection had none of the usual risk factors. Indeed, marriage was the only risk factor identified for infected pregnant women in this area. A further revelation was the presence of bisexuality in men as a risk factor in this population.
One of our programs focused on ensuring that pregnant women with HIV received prophylactic medication to prevent transmission of HIV during childbirth.
We had the misfortune of encountering a young pregnant lady who, on learning of her HIV status, became so depressed that she disengaged entirely from any health service. She refused to further contact, and we feared that she would carry her pregnancy without any protective intervention- for herself or for her child.
Fortunately, a young lady from our team, working as a peer counsellor (herself living with HIV) decided to reach beyond the clinic. She built trust with the family and even the neighbours of the pregnant woman. Through this network of care, she ensured she would be informed when labour began.
When the time came, she arrived during delivery and ensured that both mother and child received prophylactic medication. Here, we learned the power of true dedication and determination, to the cause and to ensure that others did not suffer the same affliction.
During the same time, it was conventional wisdom that most truck drivers were infected with HIV and were instrumental in spreading the infection along the length and breadth of India. What we found is that at baseline, 2.1% of drivers were HIV infected and 34% who reported having contact with Female Sex Workers (FSWs) had contact within the previous six months. Those who washed their hands post defecation were less likely to report genital symptoms and have sex with a Female Sex Worker. After an awareness campaign, there were no changes in sexual risk-taking behaviour, however, hygiene behaviour improved from baseline. Personal hygiene habits, like handwashing, seem to be a modifiable behaviour after a modest intervention, whereas HIV risk-taking behaviour was not in high-risk men in India. Clearly, we had much to learn about modifying behaviour for mitigating the risk of infection.
I must say the first few years we struggled with apathy and, at times, outright hostility, mainly from the medical fraternity. We set about reducing the burden of stigma and discrimination by building APAIDSCON, one of the most significant public-private partnerships to train health care professionals across 20 private medical colleges and many private hospitals across the undivided state of Andhra Pradesh. This consortium was a role model in recruiting over 10,000 health professionals into stigma-free services for people with HIV infection. The consortium was in many ways in the forefront of voluntary counselling and testing as well as treatment for HIV related complications.
Over the next few years, we at SHARE INDIA have had the opportunity to work closely with the National AIDS Control Organization, spearheading the response to the HIV pandemic in India. This strategy has progressively evolved from creating awareness and prevention campaigns to the current strategy of ensuring testing and treatment for all with highly effective and reliable antiretroviral treatment regimens. NACO was instrumental advocating for the 2016 cabinet decision to amend provisions of the 2014 HIV and AIDS Bill providing for enhanced legal protections for persons with HIV infection against discrimination. These efforts eventually supported the final passage of The Human Immunodeficiency Virus and Acquired Immune Deficiency Syndrome (Prevention and Control) Act, 2017. The Act, implemented in 2018 is a landmark legislation providing legal protection to persons with HIV.
Working in concert with NACO, we have been privileged to witness and, in many ways participate in the incredible work addressing the HIV pandemic in India. Key accomplishments are the establishment of a nationwide network of testing and treatment centres. According to NACO between 2010 and 2024, India achieved 48.7 per cent decline in annual new HIV infections, 81.4 per cent reduction in AIDS-related deaths and 74.6 per cent decline in mother-to-child HIV transmission. HIV testing increased from 4.13 crore (2020–21) to 6.62 crore (2024–25);Access to antiretroviral treatment rose from 14.94 lakh to 18.60 lakh (PLHIV); andViral load testing nearly doubled from 8.90 lakh to 15.98 lakh in the same period.
It is a matter of immense pride for us to have worked closely with NACO to help establish the viral load testing centres and establish world class quality assurance systems for the same. SHARE INDIA has been part of many innovative and truly inspiring efforts to ensure proper treatment of persons infected and affected by HIV.
Looking ahead, we still unfortunately continue to see individuals newly infected with HIV and sometimes with advanced illness. A vaccine would undoubtedly be a great boon to our efforts to eliminate HIV infection. Nevertheless, we know from incontrovertible evidence that effective antiviral treatment is now available in India, free to all, and can help prevent the spread of the infection. So our challenge remains to spread awareness further to enhance testing by destigmatizing and demystifying HIV infection. We need to revisit and remember the lessons we learned in the early years of the pandemic from persons infected with HIV about the value of social justice and caring for all as essential to addressing any public health threat.
Forty years ago, we did not know where this journey would lead. Today, we know where it must go: toward dignity, access, justice, and care without fear. Miles remain, but we are no longer walking in the dark.
References:
Schneider, J. A., Saluja, G. S., Oruganti, G., Dass, S., Tolentino, J., Laumann, E. O., Yeldandi, V. and Pitrak, D. (2007) ‘HIV infection dynamics in rural Andhra Pradesh south India: A sexual-network analysis exploratory study’, AIDS Care. 2007; 19(9): 1171-1176.
Schneider JA, Dude A, Dinaker M, Kumar V, Laumann EO, Holloway-Beth A, Oruganti G, Saluja GS, Chundi V, Yeldandi V, Mayer KH. General Hygiene, Sexual Risk Behavior and HIV Prevalence in Truck Drivers from Andhra Pradesh, South India: Implications for Prevention Interventions. International Journal of STD & AIDS. 2009; 20(1): 39-45.
Sudha Sivaram, Gurcharan Singh Saluja, Manik Das, P. Sudhakar Reddy and Vijay Yeldandi, Reasons for Seeking HIV-test: Evidence from a Private Hospital in Rural Andhra Pradesh, India. J HEALTH POPUL NUTR 2008 Dec;26(4):431-441
Schneider JA, Dandona R, Pasupneti S, Lakshmi V, Liao C, Yeldandi V, Mayer K. “Initial commitment to pre-exposure prophylaxis and circumcision for HIV prevention amongst Indian truck drivers” . PLoS ONE. 2010 Jul 30;5(7):e11922.
Schneider JA, Michaels S, Gandham SR, McFadden R, Liao C, Yeldandi VV, Oruganti G. A protective effect of circumcision among receptive male sex partners of Indian men who have sex with men. AIDS Behav. 2012 Feb;16(2):350-9. PMID: 21681562
Private sector involvement to enhance skills of physicians to manage HIV cases – Andhra Pradesh experience. Misra, M., Reddy Allam, R., Varma, K. S., Dutta, A., Guru Rajesh, J., Oruganti, G. & Yeldandi, V. V. Oct 1 2012 In : Indian Journal of Public Health Research and Development. 3, 4, p. 120-125.
Snyder H, Yeldandi VV, Prem Kumar G, Liao C, Lakshmi V, Gandham SR, Muppudi U, Oruganti G, Schneider JA. Field-based video pre-test counseling, oral testing, and telephonic post-test counseling: implementation of an HIV field testing package among high-risk Indian men. AIDS Educ Prev. 2012 Aug;24(4):309-26. PMID: 22827901
Satyanarayan S1, Kapur A, Azhar S, Yeldandi V, Schneider JA. Women Connected to at Risk Indian Men Who Have Sex with Men: An Unexplored Network. AIDS Behav. 2014 Nov 18.
Pre-exposure prophylaxis: awareness, acceptability and risk compensation behaviour among men who have sex with men and the transgender population. Uthappa CK, Allam RR, Pant R, Pal S, Dinaker M, Oruganti G, Yeldandi VV. HIV Med. HIV Med. 2018 Apr;19(4):243-251. doi: 10.1111/hiv.12572. Epub 2017 Nov 27.
Strengthening HIV/AIDS Response: Program Evaluation of India’s Largest Public-Private Partnership Consortium for HIV/AIDS Care and Treatment. Ramesh Reddy Allam., Ganesh Oruganti, Chengappa K.U., Naidu C.H.S., Vijay V. Yeldandi. Indian Journal of Preventive Medicine . Volume 5, Issue 2, Jul-Dec 2017, Pages 76-82
A Gold-Standard for Entity Resolution within Sexually Transmitted Infection Networks. John Schneider, L. Philip Schumm, Maya Fraser, Vijay Yeldandi, Chuanhong Liao. Scientific Reports volume 8, Article number: 8776 (June 2018)
Factors associated with non-adherence to antiretroviral therapy among female sex workers living with HIV in Hyderabad, India. Allam RR, Takamiya M, Pant R, Gandham S, Yeldandi VV, Thomas J, Ekstrand ML, Dworkin MS. Int J STD AIDS. 2020 Jul;31(8):735-746. doi: 10.1177/0956462420920145. PMID: 32631214.
Secret lives and gender fluidity of people living with HIV in Hyderabad, India.Azhar S, Vaudrey J, Gandham S, Burr S, Oruganti G, Yeldandi V. J Community Psychol. 2021 Mar 22. doi: 10.1002/jcop.22541. Epub ahead of print. PMID: 33751572.
Associations between HIV stigma, gender, and depression among people living with HIV in Hyderabad, India. Azhar, S., Jokhakar, V., Vaudrey, J., Gandham, S., Oruganti, G., & Yeldandi, V. (2022). Journal of Community Psychology, 1– 18. https://doi.org/10.1002/jcop.22934.
Utility of the lateral flow urine lipoarabinomannan tuberculosis assay in patients with advanced HIV disease at antiretroviral therapy centres in Mumbai, India: Acharya S, Deshpande P, Asirvatham ES, Palkar A, Sarman CJ, Laxmeshwar C, et al. (2022). PLoS ONE 17(9): e0273970. https://doi.org/ 10.1371/journal.pone.0273970
Building communities of practice through case-based e-learning to prevent and manage TB among people living with HIV– India Reshu Agarwal , Upasna Agarwal , Chinmoyee Das , Ramesh Allam Reddy , Rashmi Pant , Christine Ho , B. Ravi Kumar , Vandana Dabla , Patrick K. Moonan , Melissa Nyendak , Sunil Anand , Anoop Kumar Puri , Sanjay K. Mattoo , Kuldeep Singh Sachdeva , Vijay V. Yeldandi and Rohit Sarin. BMC Infectious Diseases (2022) 22:967 https://doi.org/10.1186/s12879-022-07957-4
Implementation of point-of-care testing and prevalence of cryptococcal antigenaemia among patients with advanced HIV disease in Mumbai, India. Shrikala Acharya, Ramesh Reddy Allam , Vijay Kumar Karanjkar , Dhirubhai Rathod , Raman Mahajan , Prashant Deshpande, Amol Palkar , Shashikant Todmal , Sagar Koli , Sachin Dhande , Jayesh Dale , Vijay V Yeldandi , Amit Harshana , Reshu Agarwal , Sunita Upadhyaya , Melissa Nyendak. PMID: 37349096. DOI: 10.1136/bmjopen-2022-070500
A review of Tenofovir Disoproxil Fumarate associated nephrotoxicity among People Living with HIV: Burden, risk factors and solutions. Asirvatham ES, Ranjan V, Garg C, Sarman CJ, Periasamy M, Yeldandi V, Upadhyaya S, Rao B. Clinical Epidemiology and Global Health (2023), doi: https://doi.org/10.1016/j.cegh.2023.101462.
Work-Related Barriers to Access to Health Care for People Living with HIV in Hyderabad, India. Azhar S, Dean C, Lerner R, Gandham S, Oruganti G, Yeldandi V.Int J Soc Determinants Health, Health Serv. 2024 Jul;54(3):260-271. doi: 10.1177/27551938241234223. Epub 2024 Mar 31.PMID: 38557317
Acceptability, usability, and willingness to pay for HIV self-test kits distributed through community-based, PLHIV network-led and private practitioners models in India: Results from the STAR III Initiative. Chinmay Laxmeshwar, Asha Hegde, Alpana Dange, Kannan Mariyappan, Manish Soosai, Sandeep Mane, Murugesan Sivasubramanian, Mahesh Doddamane, Madhuri Mukherjee, G. S. Shreenivas, Manoj Pardesi, Vinod Jambhale, Venkateswara Rao Pakkela, Vijayaraman Arumugam, Vedant Rungta, Yashika Bansal, Jatin Chaudary, Vijay Yeldandi, Mahalingam Periasamy, Chengappa Uthappa, Sudhir Chawla, Sunita Upadhyaya, Melissa Nyendak, Venkatesan Chakrapani, Sheela Godbole, Vinita Verma, Bhawani Singh Kushwaha, Chinmoyee Das, Shobini Rajan, Anoop Kumar Puri, J. V. R. Prasada Rao, Tarun Bhatnagar, D. C. S. Reddy, Kimberly Green. Journal of the International AIDS Society. https://doi.org/10.1002/jia2.26348
Combating HIV-related Stigma and Discrimination: A Crucial Imperative in India. Samridhi Uniyal, LLB, Garima Sharma, M.A., Vijay Yeldandi, M.D., Shikha Dhawan, Ph.D. Journal of the American Association of Physicians of Indian Origin – JAAPI 4(1, 2):2024
Integrating HIV advanced disease management into a routine program setting: cohort from Mumbai, India. Shrikala Acharya, Ramesh Reddy Allam, Vijay Kumar Karanjkar, Dhirubhai Rathod, Prashant Deshpande, Amol Palkar, Shashikant Todmal, Sagar Koli, Sachin Dhande, Nalini Chava, Vijay V Yeldandi, Amit Harshana, Reshu Agarwal, Sunita Upadhyaya and Melissa Nyendak. BMC Health Services Research (2025) 25:595. https://doi.org/10.1186/s12913-025-12572-5
Long-term Protection From Tuberculosis Preventive Treatment Among People With Human Immunodeficiency Virus in a High-Burden Tuberculosis Setting: An Observational Cohort Study From India. Reshu Agarwal, Melissa Nyendak, Nalini Chava, Ramesh R Allam, Patrick K Moonan, Chakravarthy S Sriram, Ramesam Ganti, Praveen K Ragi, Ajit R Polsani, Vijay V Yeldandi, Christine Ho, Rajendra P Prasad, JayaKrishna Kurada, Kameswara Prasad, Manjula Thogarucheeti, , Clinical Infectious Diseases, 2025; ciaf322, https://doi.org/10.1093/cid/ciaf322
Abstracts and Presentations:
HIV Infection in Pregnant Women From Rural South India compared to HIV Infection in Volunteer Blood Donors from Urban South India. Yeldandi V, Yeldandi A, Chundi V, Saluja G S, Oruganti G, Dass S M, Beerum N, Reddy P S. The 41st Annual Meeting of IDSA, October 9-12, 2003, San Diego, CA.
Development of a HIV Voluntary Counseling and Testing Model for a rural population in southern India. Sivaram S, Saluja GS, Manik Das, Reddy PS and Yeldandi V. Poster presentation at the XV International AIDS Conference, Bangkok Thailand, 11-16 July 2004.
HIV Infection in Rural South India: A Sexual Network Analysis. Schneider JA, Saluja GS, Yeldandi V, Tolentino J, Oruganti G, Dass S, Reddy PS, Pitrak D. The 43rd Annual Meeting of IDSA, October 6- 9, 2005, San Francisco, CA.
HIV Epidemiology in Rural Ranga Reddy District (HERRD): Examining Sexual Networks in South India. Schneider JA, Gurcharan S, Oruganti G, Dass S, Tolentino J, Reddy PS, Laumann EO, Pitrak D, Yeldandi V . Presentation at the Chicago Area Infectious Diseases Society Annual Meeting, June 6, 2006, Chicago, IL
Discordance between peripheral blood smear (PBS) and bone marrow examination (BME) amongst forty anti-retroviral naïve HIV infected inpatients in Andhra Pradesh South India. Warrier AR, Dinaker M, Mayer K, Yeldandi V, Schneider JA. Infectious Diseases Society of India Annual Meeting, February 9-11, 2007, Mumbai, India
HIV Testing and an Information-Motivation (IM) Intervention in South Indian Truck Drivers in Andhra Pradesh. Schneider J, Kassen M., Dinaker M., Laumann E., Oruganti G., Dass S., Saluja G., Chundi V., Vijayaraghavan K., Kumar V., Mayer K., Yeldandi V. 4th International AIDS Society Conference, July 22-25, 2007, Sydney, Australia. #A-042-0150-03785
Relationship Between General Hygiene, Risk Taking Behavior and HIV Infection in Truck Drivers followed Longitudinally in the High Prevalence State of Andhra Pradesh India. Schneider JA, Dude A, Dinaker M, Kumar V, Laumann EO, Holloway-Beth A, Oruganti G, Singh Saluja G, Chundi V, Yeldandi V, Mayer KH. Department of Medicine Research Day, Department of Medicine, University of Chicago, April 2008.
HIV Infection and Sexual Risk Behavior Among Truck Drivers (TD) Employed by a Large Corporation in the High Prevalence State of Andhra Pradesh (AP), South India. Dude AM, Holloway-Beth A, Dinaker M, Laumann EO, Oruganti G, Kumar SG, Kumar V, Saluja GS, Yeldandi V, Mayer K, Schneider JA. 136th APHA Annual Meeting & Exposition, October 25-29, 2008, San Diego, CA.
Comparison of Acceptability Towards Circumcision (Circ), Pre-Exposure Prophylaxis (PREP) and Herpes Simplex Suppression (HSV-S) as Novel HIV Prevention Strategies Amongst Truck Drivers in India. J. Schneider, G. Oruganti, S. Pasupneti, V. Yeldandi, V. Lakshmi, R. Dandona, K. Mayer. 5th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2009) Cape Town, South Africa, 19-22 July 2009.
HIV Risk Factors, Immunologic Profile and Linkage to Care amongst Men who Have sex with Men (MSM) in Hyderabad India. Schneider J, Rajender D, Snyder H, Oruganti G, Liao C, Mayer K, Yeldandi V. 18th International AIDS Conference, Vienna Austria, 18-23 July 2010.
Feasibility and acceptability of oral testing, multimedia pre-test counseling and telephonic post-test counseling amongst truck-drivers (TD) and men who have sex with men (MSM) in Andhra Pradesh (AP) India. Schneider J, Snyder H, Kumar P, Liao C, Lakshmi V, Reddy D, Muppudi U, Oruganti G, Yeldandi V. 18th International AIDS Conference, Vienna Austria, 18-23 July 2010.
An intervention to strengthen the HIV clinical management skills of physicians – A private medical college experience from Andhra Pradesh. Vijay V Yeldandi, Ganesh Oruganti, Jammy Guru Rajesh, Ramesh Reddy Allam, Meenakshi Misra, Srinivasa Varma, Sreenivasan V. 18th International AIDS Conference, Vienna Austria, 18-23 July 2010.
Implementing Routine HIV Testing. Ganesh Oruganti, Vijay Yeldandi, Jammy Guru Rajesh, Ramesh Reddy Allam, Prasanth Venela, Sreenivasan, Simhachalam Naidu. 18th International AIDS Conference, Vienna Austria, 18-23 July 2010.
Comprehensive Out reaches model – An inspirational effort in prevention of parent to child transmission program in Andhra Pradesh. Ganesh Oruganti, Vijay Yeldandi, Jammy Guru Rajesh, Ramesh Reddy Allam, Prasanth Venela, Simhachalam Naidu, Meenakshi Misra, Sreenivas Varma. 18th International AIDS Conference, Vienna Austria, 18-23 July 2010.
Situational analysis of HIV testing in private laboratories in Hyderabad, India. Ganesh Oruganti, Vijay Yeldandi, Jammy Guru Rajesh, Ramesh Reddy Allam, Prasanth Venela, Sreenivasan, Anchan Chugh. 18th International AIDS Conference, Vienna Austria, 18-23 July 2010.
APAIDSCON Program Evaluation of the largest Private Public Partnership consortium for HIV/AIDS care and treatment in India. Ramesh Reddy Allam, Ganesh Oruganti, Chengappa KU, Naidu CHS, Jammy Rajesh and Vijay V Yeldandi. 17th International Congress on Infectious Diseases. Hyderabad, India, March 2 to 5, 2016.
Private Public Partnership for Stigma free HIV service delivery in APAIDSCON Network in India. Ramesh Reddy Allam, Ganesh Oruganti, and Vijay V Yeldandi. 17th International Congress on Infectious Diseases. Hyderabad, India, March 2 to 5, 2016.
Pre-exposure Prophylaxis (PrEP): Attitudes, Preferences and Risk Compensation Behavior among Men who have Sex with other Men (MSM) in India. Chengappa K Uthappa, Suman Pal, Rashmi Panth, Ramesh R Allam, Ganesh Oruganti, Manjunath Dinaker, Vijay Yeldandi. 17th International Congress on Infectious Diseases. Hyderabad, India, March 2 to 5, 2016.
Implementation of Quality Management System in HIV testing laboratories under National AIDS Control Organization in Kolkata translating to better health outcomes for PLHIV. Samrat Banerjee, Dr. Jayesh Dale, Dr. Shikha Dhawan, Dr. Ramesh Reddy Allam, Dr. Ganesh Oruganti, Dr. Vijay Yeldandi. Poster presentation in “3rd International Conference on Translational Research’ Kolkata 22-25 September 2017.
Design and implementation of in-service trainings on TB prevention and management among PLHIV in India: PERT application.: Ramesh. R. Allam, Rashmi Pant, Chengappa Uthappa, R, Ganesh Oruganti, Vijay V. Yeldandi, Kuldeep Sachdeva, R. S. Gupta. The 50th Union World Conference on Lung Health Hyderabad India October 30 to November 2, 2019.
Ensuring Universal Access to Routine Viral Load Testing through Diagnostics Network Optimization of Public Viral Load Laboratories in India. Bhawna Rao, Shivali Kamal, Smita Mishra, Lokabhiraman, Chhavi Garg, Varsha Ranjan, Meher Vani, Mahesh Suryadeva, Edwin Sam, Vijay Yeldandi, Sanjeev Verma, Melissa Nyendak, Sunita Upadhyaya. 6th Biennial ASLM Conference. Cape Town South Africa 12-15 December 2023.
It is Beyond Anonymity: Reasons why PLHIV Continue to Opt for ART Services From a Distant Location Compared to Place of Residence, Andhra Pradesh. Ramesh Allam, Praveen Kumar Ragi, Nalini Chava, Ramesam Ganti, Jaya Krishna Kurada, Ajit Polsani, Prabhu Turaka, Vijay V. Yeldandi, Rajendra Prasad Poluru, Kameswara Prasad Yepuru, Melissa Nyendak. Presented at AIDS 2024. The 25th International AIDS Conference.
Integrated Response for The Prevention of Hepatitis B Through Vaccination as Part of Routine ART Care, Andhra Pradesh 2023-2024. Ramesh Allam, Kameshwara Prasad, Jaya Krishna, Nalini Chava, Praveen Kumar, Rajendra Prasad, Neelima, Prabhu, Melissa Nyendak. Presented at AIDS 2024. The 25th International AIDS Conference
Predictors of Recurrent Tuberculosis among People Living with HIV under routine ART Care: An observational cohort study, Andhra Pradesh, India 2024. Siri Attada, Manjula Thogarucheeti, Kameswara Prasad Yepuru, Ramesh Reddy Allam, Nalini Chava, Ganti Ramesam, Ragi Praveen Kumar, Polasani Ajit Rao, JayaKrishna Kurada, Vijay V Yeldandi, Prabhu Turaka, Rajendra Prasad Poluru, Chakravarthy S S, Patrick Nadol. Presented at IAS 2025. 13-17 July 2025. Kigali, Rwanda.
Integrated Management of Hepatitis B among pregnant women with HIV as a part of routine care at antiretroviral therapy clinics, Andhra Pradesh, India. Siri Attada, Manjula Thogarucheeti, Neelima Surapaneni, Kameswara Prasad Yepuru, Ramesh Reddy Allam, Nalini Chava, Reshu Agarwal, Ganti Ramesam, Ragi Praveen Kumar, Polasani Ajit Rao, JayaKrishna Kurada, Vijay V Yeldandi, Prabhu Turaka, Rajendra Prasad Poluru, Chakravarthy S S, Patrick Nadol, Chinmoyee Das. Presented at IAS 2025. 13-17 July 2025. Kigali, Rwanda.
Hepatitis B Surface antigen positivity and associated factors among people living with HIV accessing care at antiretroviral therapy clinics, Andhra Pradesh, India, 2024. Siri Attada, Manjula Thogarucheeti, Neelima Surapaneni, Kameswara Prasad Yepuru, Ramesh Reddy Allam, Nalini Chava, Reshu Agarwal, Ganti Ramesam, Ragi Praveen Kumar, Polasani Ajit Rao, JayaKrishna Kurada, Vijay V Yeldandi, Prabhu Turaka, Rajendra Prasad Poluru, Chakravarthy S S, Patrick Nadol, Chinmoyee Das. Presented at IAS 2025. 13-17 July 2025. Kigali, Rwanda.
Implementing short course Tuberculosis Preventive therapy (1HP) among People Living with HIV in routine program setting, Andhra Pradesh, India, 2024. Siri Attada, Manjula Thogarucheeti, Kameswara Prasad Yepuru, Ramesh Reddy Allam, Nalini Chava, Ganti Ramesam, Ragi Praveen Kumar, Polasani Ajit Rao, JayaKrishna Kurada, Vijay V Yeldandi, Prabhu Turaka, Rajendra Prasad Poluru, Chakravarthy S S, Patrick Nadol, Chinmoyee Das. Presented at IAS 2025. 13-17 July 2025. Kigali, Rwanda.